Compugen Sells Cancer Drug Royalties to AstraZeneca for $90M

source:

[1] Compugen Monetizes Portion of Rilvegostomig Future Royalties to AstraZeneca for Up to $90 Million (https://finance.yahoo.com/news/compugen-monet ...)

Compugen Sells Cancer Drug Royalties to AstraZeneca for $90M

Related News

Babcock & Wilcox Secures $40M Refinery Contract

Tesla Profits Plunge 53% as Politics Cost 1.26M Sales

Mizuho Lifts Tesla Target to $530 on Robotaxi Hopes